Advisor Group Holdings, Inc. Aerie Pharmaceuticals Inc Call Options Transaction History
Advisor Group Holdings, Inc.
- $42.2 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AERI
# of Institutions
3Shares Held
2.4MCall Options Held
0Put Options Held
0About AERIE PHARMACEUTICALS INC
- Ticker AERI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,390,500
- Description
- Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...